Table 1 Clinical features of the m.3243 A > G carriers

From: Clinical characteristics and hearing impairment in carriers of the m.3243 A > G variant

Number of subjects

37

Sex (n)

 Female

17 (46%)

 male

20 (54%)

Heteroplasmy:% (range)

<1–72

Age adjusted Heteroplasmy (range)

5–138

Height:cm 20 y.o. and over (range:md)

 Female

140–163.4 (150)

 male

154.2–168.3 (163)

BMI:kg/m2 (range:md)

11.7–26 (18.3)

Complications (n)

 HL

32 (86%)

 Diabetes

26 (70%)

 heart disease

9 (24%)

 kidney disease

6 (16%)

 Developmental delays

1 (2.7%)

 MELAS

6 (16%)

 muscle weakness

6 (16%)

 eye disease

2 (5.4%)

 CPEO

1 (2.7%)

Family history of HL(-) (n)

3

Age at genetic test:y.o. (range:md)

5–78 (43)

Age at onset of HL(n = 32)

 0–5 y.o.

0

 6–10 y.o.

0

 11–20 y.o.

11 (34%)

 >20 y.o.

21 (66%)

Age of using hearing aid:y.o. (range:md)

13–67 (40)

Severity of HL※ (n)

 mild (21–40 dB)

11 (30%)

 moderate (41–70 dB)

14 (38%)

 severe (71–90 dB)

6 (16%)

 profound (91dB-)

1 (2.7%)

 normal (<20 dB)

5 (13%)

Audiometric configuration (n)

 Flat

16 (50%)

 gently sloping

11 (35%)

 steepy sloping

0

 profound

1 (3%)

 reverse U-shaped

4 (12%)

  1. HL hearing loss, y.o. years old, dB decibel, md mean data,
  2. MELAS mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
  3. CPEO chronic progressive external ophthalmoplegia
  4. ※Hearing level of worse side